Aldamiz L - Search Results

1

Dietary threonine reduces plasma phenylalanine levels in patients with hyperphenylalaninemia.

Sanjurjo P, Aldamiz L, Georgi G, Jelinek J, Ruiz JI, Boehm G. Sanjurjo P, et al. Among authors: aldamiz l. J Pediatr Gastroenterol Nutr. 2003 Jan;36(1):23-6. doi: 10.1097/00005176-200301000-00007. J Pediatr Gastroenterol Nutr. 2003. PMID: 12499992 Clinical Trial.

2

Tissue antioxidant capacity and bacterial translocation under total parenteral nutrition.

Eizaguirre I, Aldámiz L, Aldazábal P, García Urkia N, Asensio AB, Bachiller P, García Arenzana JM, Ruiz JL, Sanjurjo P, Perez Nanclares G. Eizaguirre I, et al. Among authors: aldamiz l. Pediatr Surg Int. 2001 May;17(4):280-3. doi: 10.1007/s003830100594. Pediatr Surg Int. 2001. PMID: 11409162

3

[Tissue antioxidant capacity and bacterial translocation in parenteral nutrition. Experimental study].

Eizaguirre I, Aldámiz L, Aldazábal P, García N, Asensio AB, Bachiller P, García Arenzana JM, Sanjurjo P, Pérez Nanclares G. Eizaguirre I, et al. Among authors: aldamiz l. Cir Pediatr. 2002 Jan;15(1):29-33. Cir Pediatr. 2002. PMID: 12025473 Spanish.

4

Development of a mnemonic screening tool for identifying subjects with Hunter syndrome.

Cohn GM, Morin I, Whiteman DA; Hunter Outcome Survey Investigators. Cohn GM, et al. Eur J Pediatr. 2013 Jul;172(7):965-70. doi: 10.1007/s00431-013-1967-x. Epub 2013 Mar 7. Eur J Pediatr. 2013. PMID: 23468122 Free PMC article.

5

Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS).

Burton BK, Whiteman DA; HOS Investigators. Burton BK, et al. Mol Genet Metab. 2011 Jun;103(2):113-20. doi: 10.1016/j.ymgme.2011.02.018. Epub 2011 Mar 4. Mol Genet Metab. 2011. PMID: 21439875

6

Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey.

Mendelsohn NJ, Harmatz P, Bodamer O, Burton BK, Giugliani R, Jones SA, Lampe C, Malm G, Steiner RD, Parini R; Hunter Outcome Survey Investigators. Mendelsohn NJ, et al. Genet Med. 2010 Dec;12(12):816-22. doi: 10.1097/GIM.0b013e3181f6e74d. Genet Med. 2010. PMID: 21045710 Free article.

7

Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome Survey.

Burton BK, Guffon N, Roberts J, van der Ploeg AT, Jones SA; HOS investigators. Burton BK, et al. Mol Genet Metab. 2010 Oct-Nov;101(2-3):123-9. doi: 10.1016/j.ymgme.2010.06.011. Epub 2010 Jun 23. Mol Genet Metab. 2010. PMID: 20638311

8

Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS).

Jones SA, Almássy Z, Beck M, Burt K, Clarke JT, Giugliani R, Hendriksz C, Kroepfl T, Lavery L, Lin SP, Malm G, Ramaswami U, Tincheva R, Wraith JE; HOS Investigators. Jones SA, et al. J Inherit Metab Dis. 2009 Aug;32(4):534-43. doi: 10.1007/s10545-009-1119-7. Epub 2009 Jul 14. J Inherit Metab Dis. 2009. PMID: 19597960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters